TCT-683 Pulmonary artery denervation to treat pulmonary arterial hypertension: a single-center, prospective, first-in-man PADN-1 study  by Chen, Shao Liang et al.
www.jacctctabstracts2013.com TUESDAY, OCTOBER 29, 2013, 3:30 PM–5:30 PM
P
O
S
T
E
R
SConclusions: ICE and higher annual hospital volume are associated with lower
complication rates. Cardiac and vascular complications remain the major concern for
LAA closure.
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Background: Paravalvular leaks (PVL)affect up to 17% of all surgically implanted
prosthetic valves. Reoperation is associated with high morbidity and mortality.
Transcatheter transapical (TA) closure is an emerging alternative for selected high-risk
patients with PVL. The aim of this study is to compare the in-hospital outcomes of
patients who underwent surgery and TA-closure for PVL in our single-center
experience.
Methods: From October 2000 and June 2013, 136 patients with PVL were treated in
our Institution: 122 patients (89.7%%) underwent surgery (68% mitral-PVL; 32%
aortic-PVL) and 14 patients (10.3%) underwent TA closure (all the pts had mitral
PVL; 1 case had combined mitral and aortic PVLs). All the TA procedures were
performed under general anesthesia in a hybrid operative room: in all but 1 case an
Amplatzer Vascular Plug III device was utilized.
Results: Baseline features of the patients were comparable in terms of age (p¼0.9),
associated coronary artery disease (p¼0.6), chronic renal failure (p¼0.2), previous
endocarditis (p¼0.08), concomitant atrial ﬁbrillation (p¼0.4), while COPD was more
prevalent in TA group (P¼0.002). Log-EuroScore was 1511% and 198% in
surgical and TA group respectively (p¼0.03). Most of the patients were in NYHA
class III-IV (60% Vs 78%; p¼0.1); 41% of surgical patients and 86% of TA patients
were at their second of more reoperation (p¼0.0001). Procedural success in TA group
was 93% (1 conversion to surgery because of the dislocation of the device). In-
hospital mortality was 10.6% in surgical group (all cardiac-related) and 0% in TA
group (p¼0.08). Mean LOS was 19 days for surgery and 9 days for TA (p¼0.1). All
the patients had less than moderate residual valve regurgitation after the procedure.
Surgical treatment was identiﬁed as risk factor for in-hospital death at multivariate
analysis (OR 1.6; p¼0.04).
Conclusions: Transcatheter TA approach is a safe and effective therapeutic option in
selected high-risk patients with PVL and it is associated with reduced risk of hospital
mortality than surgical treatment, in spite of higher predicted risk. Further studies are
needed to determine the long-term results of the two procedures.
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Background: Baroreceptors and sympathetic nerve ﬁbers are localized in or near the
bifurcation area of the main PA. We previously demonstrated that PADN completely
abolished the experimentally elevated PA pressure responses to occlusion of the left
interlobar pulmonary artery.
Methods: Out of a total of 21 patients with IPAH, 13 patients received the PADN
procedure, the other 8 patients who refused the PADN procedure were assigned to theJACC Vol 62/18/Suppl B j October 27–November 1, 2013 j TCT Abstrcontrol group. PADN was performed at the bifurcation of the main PA, and at the
ostial right and left PA. Serial echocardiography, right heart catheterization, and a
6-minute walk test (6MWT) were performed. The primary endpoints were the change
of pulmonary artery pressure (PAP), tricuspid excursion (Tei) index, and 6MWT at
3-months follow-up.
Results: Compared with the control group, at 3 months follow-up, the patients who
underwent the PADN procedure showed signiﬁcant reduction of mean PAP (from
555 mmHg to 365 mmHg, p<0.01), signiﬁcant improvement of the 6MWT (from
32421 m to 49138 m, p<0.006) and of the Tei index (from 0.30.04 to
0.500.04, p<0.001).
Conclusions: We report for the ﬁrst time the effect of PADN on functional capacity
and hemodynamics in patients with IPAH not responding optimally to medical
therapy. Further randomized study is required to conﬁrm the efﬁcacy of PADN.
(chiCTR-ONC-12002085)
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Background: Vitamin K antagonists (VKA) such as warfarin are recommended in the
Group 1 Pulmonary Hypertension (PH) cohort based on poor quality evidence.
Among proposed mechanisms of beneﬁt is that endothelial dysfunction present in
patients with Pulmonary Arterial Hypertension (PAH) causes abnormalities in coag-
ulation factors, antithrombotic factors and ﬁbrinolytic system, which ﬁnally leads to
a prothrombotic state in patients with PAH. This is supported by the fact that laminar
thrombus has been found in the typical plexiform lesions that affects small muscular
arteries and supernumerary pulmonary arteries. However, unlike Chronic Thrombo-
embolic Pulmonary Hypertension (CTEPH) the evidence base in support of anti-
coagulation in patients with PAH remains weak. We normally rely on non-invasive
tests such as CT Pulmonary Angiography (CTPA), Ventilation-Perfusion Scan (VQ),
MRI and conventional pulmonary angiography to differentiate between CTEPH and
PAH. What would happen if despite using these modalities, we are misclassifying
patients with distal diffuse CTEPH as PAH?
Methods: 11 consecutive patients diagnosed with PAH were enrolled in an ethics
approved study to undergo OCT imaging of their pulmonary arteries following routine
right heart catheterisation (RHC) at the Royal Free London NHS Foundation Trust in
London. A 6Fr Guidant Swan-Ganz type Balloon Catheter was situated and wedged
into a subsegmental pulmonary vessel. Through this catheter a LightLabImageWire
Cardiovascular imaging wire was passed into the distal vessel. An automated pullback
of the vessel was obtained the data transferred and stored on a workstation for off-line
analysis. Previous studies of these patients to rule out thromboembolic disease (CTPA,
VQ and conventional pulmonary angiography) were checked and reviewed again by
two independent and blinded nuclear and radiology consultants.
Results: 4 of these 11 patients were found to have thrombus and/or webs (indicative
of recanalised thrombus) suggesting CTEPH.
Conclusions: OCT imaging of the pulmonary vascular tree allows for the detection of
CTEPH patients previously diagnosed as PAH. These novel ﬁndings, are potentially
important as the role of VKA in PAH is under discussion.
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Background: Adequate septal rim is an important factor for device closure of atrial
septal defect (ASD). As little is known about the procedural completion in ASD
patients with multiple rim deﬁciencies, we aimed to evaluate the validity of device
closure for these patients.
Methods: Between September 2007 andMay 2013, 372 consecutive adult ASDpatients
(mean 54  17 years) were attempted for device closure using Amplatzer septal
occluder. According to TEE ﬁndings, rim deﬁciency (<5 mm) was deﬁned as supero-
anterior, infero-anterior, supero-posterior, and infero-posterior rim deﬁciencies. Patients
were divided into three groups: "sufﬁcient" group, sufﬁcient rim (n¼77); "single" group,
1 rim deﬁciency including 9 patients with infero-posterior rim deﬁciency (n¼268);
"multiple" group, more than 1 rim deﬁciencies (n¼27). Procedural success was deﬁned
as device implantation with no in-hospital serious adverse events.acts/POSTER/Non-valvular Structural Heart Disease B209
